BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24058599)

  • 1. Utilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.
    Mwanahamuntu MH; Sahasrabuddhe VV; Blevins M; Kapambwe S; Shepherd BE; Chibwesha C; Pfaendler KS; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Stringer JS; Parham GP
    PLoS One; 2013; 8(9):e74607. PubMed ID: 24058599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia.
    Kapambwe S; Sahasrabuddhe VV; Blevins M; Mwanahamuntu MH; Mudenda V; Shepherd BE; Chibwesha CJ; Pfaendler KS; Hicks ML; Vermund SH; Stringer JS; Parham GP
    J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e20-6. PubMed ID: 26322673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening outcomes in Zambia, 2010-19: a cohort study.
    Pry JM; Manasyan A; Kapambwe S; Taghavi K; Duran-Frigola M; Mwanahamuntu M; Sikazwe I; Matambo J; Mubita J; Lishimpi K; Malama K; Bolton Moore C
    Lancet Glob Health; 2021 Jun; 9(6):e832-e840. PubMed ID: 34019837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia.
    Parham GP; Mwanahamuntu MH; Kapambwe S; Muwonge R; Bateman AC; Blevins M; Chibwesha CJ; Pfaendler KS; Mudenda V; Shibemba AL; Chisele S; Mkumba G; Vwalika B; Hicks ML; Vermund SH; Chi BH; Stringer JS; Sankaranarayanan R; Sahasrabuddhe VV
    PLoS One; 2015; 10(4):e0122169. PubMed ID: 25885821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening uptake and challenges in Malawi from 2011 to 2015: retrospective cohort study.
    Msyamboza KP; Phiri T; Sichali W; Kwenda W; Kachale F
    BMC Public Health; 2016 Aug; 16(1):806. PubMed ID: 27535359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Cancer Screening Positivity Among Women Living With HIV in CDC-PEPFAR Programs 2018-2022.
    McCormick LJ; Gutreuter S; Adeoye O; Alger SX; Amado C; Bay Z; Chirwa CM; Chituwo O; Correia D; Deus M; Dirlikov E; Efuntoye T; Gunde L; Kabaghe A; Kalamya JN; Lorenzoni C; Magesa D; Mate C; Mulokoshi T; Ninsiima JC; Nyangasi M; Nyika P; Pasipamire M; Ssali M; Tefera F; Torre LA; Urso M; Wandira R; Zemburuka B; Montandon M
    J Acquir Immune Defic Syndr; 2023 Dec; 94(4):301-307. PubMed ID: 37643419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness.
    Parham GP; Mwanahamuntu MH; Sahasrabuddhe VV; Westfall AO; King KE; Chibwesha C; Pfaendler KS; Mkumba G; Mudenda V; Kapambwe S; Vermund SH; Hicks ML; Stringer JS; Chi BH
    HIV Ther; 2010; 4(6):703-722. PubMed ID: 25419240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, Predictors, and Same Day Treatment of Positive VIA Enhanced by Digital Cervicography and Histopathology Results in a Cervical Cancer Prevention Program in Cameroon.
    DeGregorio GA; Bradford LS; Manga S; Tih PM; Wamai R; Ogembo R; Sando Z; Liu Y; Schwaiger C; Rao SR; Kalmakis K; Kennedy Sheldon L; Nulah K; Welty E; Welty T; Ogembo JG
    PLoS One; 2016; 11(6):e0157319. PubMed ID: 27280882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia.
    Parham GP; Mwanahamuntu MH; Pfaendler KS; Sahasrabuddhe VV; Myung D; Mkumba G; Kapambwe S; Mwanza B; Chibwesha C; Hicks ML; Stringer JS
    J Low Genit Tract Dis; 2010 Jul; 14(3):167-73. PubMed ID: 20592550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing a Fee-for-Service Cervical Cancer Screening and Treatment Program in Cameroon: Challenges and Opportunities.
    DeGregorio G; Manga S; Kiyang E; Manjuh F; Bradford L; Cholli P; Wamai R; Ogembo R; Sando Z; Liu Y; Sheldon LK; Nulah K; Welty T; Welty E; Ogembo JG
    Oncologist; 2017 Jul; 22(7):850-859. PubMed ID: 28536303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher educational attainment associated with reduced likelihood of abnormal cervical lesions among Zambian women - a cross sectional study.
    Hamoonga TE; Likwa RN; Musonda P; Michelo C
    BMC Cancer; 2017 Oct; 17(1):681. PubMed ID: 29029626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical Cancer Stigma in Rural Kenya: What Does HIV Have to Do with It?
    Rosser JI; Njoroge B; Huchko MJ
    J Cancer Educ; 2016 Jun; 31(2):413-8. PubMed ID: 25982550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Cervical Cancer Screening Knowledge and Practices by HIV Status and Geographic Location: Implication for Program Implementation in Zambia.
    Nyambe N; Hoover S; Pinder LF; Chibwesha CJ; Kapambwe S; Parham G; Subramanian S
    Afr J Reprod Health; 2018 Dec; 22(4):92-101. PubMed ID: 30632726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
    Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
    Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.
    Assefa AA; Astawesegn FH; Eshetu B
    BMC Health Serv Res; 2019 Nov; 19(1):847. PubMed ID: 31744548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
    PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.
    Fentie AM; Tadesse TB; Gebretekle GB
    BMC Womens Health; 2020 Jul; 20(1):147. PubMed ID: 32677933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia.
    Korn AK; Muzingwani L; O'Bryan G; Ensminger A; Boylan AD; Kafidi EL; Kashali M; Ashipala L; Nitschke AM; Dziuban EJ; Forster N; Eckert LO; O'Malley G
    PLoS One; 2022; 17(2):e0263920. PubMed ID: 35171941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and barriers to cervical cancer screening among human immunodeficiency virus-positive women in Sub Saharan Africa: a systematic review and meta-analysis.
    Mengesha MB; Chekole TT; Hidru HD
    BMC Womens Health; 2023 Jun; 23(1):338. PubMed ID: 37370091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.